


European Commission Approves Upadacitinib for Psoriatic Arthritis & Ankylosing Spondylitis

Risankizumab May Improve Symptoms of PsA

Study Shows Psoriatic Arthritis Impacts Women More Than Men

FDA Approves Golimumab for Patients with pJIA & Psoriatic Arthritis

Guselkumab Approved for PsA

2 Pediatric Indications Sought for Golimumab

Apremilast Most Helpful for Mild to Moderate Psoriatic Arthritis

Risankizumab & Apremilast Come to Market in Canada

Tildrakizumab Promising for Psoriasis in Patients with PsA
- 1
- 2
- 3
- …
- 12
- Next Page »